These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16098315)

  • 1. Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and coronary artery disease.
    Nambi V; Buergler JM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF
    Am J Cardiol; 2005 Aug; 96(4):580-1. PubMed ID: 16098315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysis.
    van Dockum WG; Kuijer JP; Götte MJ; Ten Cate FJ; Ten Berg JM; Beek AM; Twisk JW; Marcus JT; Visser CA; van Rossum AC
    Eur Heart J; 2006 Dec; 27(23):2833-9. PubMed ID: 17098761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular outflow tract obstruction in the presence of asymmetric septal hypertrophy and accessory mitral valve tissue treated with alcohol septal ablation.
    Kim MS; Klein AJ; Groves BM; Quaife RA; Salcedo EE
    Eur J Echocardiogr; 2008 Sep; 9(5):720-4. PubMed ID: 18490281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy.
    Chang SM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF
    Circulation; 2004 Feb; 109(7):824-7. PubMed ID: 14967729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of alcohol septal ablation in patients with hypertrophic cardiomyopathy on the electrocardiographic pattern.
    Coakley E; Steinberg DH; Tibrewala A; Asch F; Pichard AD; Kent KM; Lindsay J
    Am J Cardiol; 2008 Sep; 102(5):621-4. PubMed ID: 18721524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol septal ablation versus surgical myectomy: a patient with obstructive HCM.
    La Canna G; Airoldi F; Capritti E; Grimaldi A; Colombo A; Alfieri O
    Nat Clin Pract Cardiovasc Med; 2007 Oct; 4(10):570-6. PubMed ID: 17893685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Percutaneous transluminal septal ablation with ethanol in hypertrophic obstructive cardiomyopathy: a case report].
    Sakakibara M; Abe S; Fusegawa Y; Nakajima T; Iwata O; Goto S; Shiina Y; Handa S
    J Cardiol; 1999 Jul; 34(1):35-40. PubMed ID: 10422624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term outcome of a patient with hypertrophic obstructive cardiomyopathy treated by alcohol septal transcoronary ablation].
    Pillière R; Gerardin B; Petitier H; Hue S; Raymond P; N'Guyen A; Dubourg O
    Arch Mal Coeur Vaiss; 2002 Mar; 95(3):213-7. PubMed ID: 11998337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coil embolization of septal artery as a treatment for hypertrophic obstructive cardiomyopathy.
    Bahl A
    Indian Heart J; 2007; 59(4):382. PubMed ID: 19126950
    [No Abstract]   [Full Text] [Related]  

  • 12. [The potential of magnetic resonance imaging for the surveillance of septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A case report].
    Chassaing S; Garrigoux P; Redheuil A; Blanchard D; Bar O; Maudière A; Mousseaux E
    Arch Mal Coeur Vaiss; 2006 Sep; 99(9):828-31. PubMed ID: 17067103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Sorajja P; Binder J; Nishimura RA; Holmes DR; Rihal CS; Gersh BJ; Bresnahan JF; Ommen SR
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E58-67. PubMed ID: 22511295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    van Dockum WG; Beek AM; ten Cate FJ; ten Berg JM; Bondarenko O; Götte MJ; Twisk JW; Hofman MB; Visser CA; van Rossum AC
    Circulation; 2005 May; 111(19):2503-8. PubMed ID: 15867172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
    Seggewiss H; Rigopoulos A; Welge D; Ziemssen P; Faber L
    Clin Res Cardiol; 2007 Dec; 96(12):856-63. PubMed ID: 17891517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Abbas AE; Brewington SD; Dixon SR; Grines CL; O'Neill WW
    J Interv Cardiol; 2005 Jun; 18(3):155-62. PubMed ID: 15966918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Doppler echocardiographic evaluation of left ventricular diastolic function in patients with hypertrophic obstructive cardiomyopathy after alcohol septal ablation in acute and long-term follow up].
    Wojtarowicz A; Kornacewicz-Jach Z; Kaźmierczak J; Szamlewski P; Gil R; Lewandowski M
    Pol Merkur Lekarski; 2002 Jul; 13(73):25-8. PubMed ID: 12362500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous transluminal septal artery ablation using polyvinyl alcohol foam particles for septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: acute and 3-year outcomes.
    Gross CM; Schulz-Menger J; Krämer J; Siegel I; Pilz B; Waigand J; Friedrich MG; Uhlich F; Dietz R
    J Endovasc Ther; 2004 Dec; 11(6):705-11. PubMed ID: 15615561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial?
    Olivotto I; Ommen SR; Maron MS; Cecchi F; Maron BJ
    J Am Coll Cardiol; 2007 Aug; 50(9):831-4. PubMed ID: 17719467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive scar myocardium in hypertrophic cardiomyopathy with severe myocardial bridge.
    Cheng MF; Wu YW; Liu YB; Huang PJ; Tzen KY; Yen RF
    Int J Cardiol; 2007 Feb; 115(3):e105-7. PubMed ID: 17049644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.